| 000 | 01071nam a2200217Ia 4500 | ||
|---|---|---|---|
| 003 | NULRC | ||
| 005 | 20250520094920.0 | ||
| 008 | 250520s9999 xx 000 0 und d | ||
| 020 | _a824784847 | ||
| 040 | _cNULRC | ||
| 050 | _aRM 301.45 .P43 1991 | ||
| 245 | 0 |
_aPharmaceutical bioequivalence / _cedited by Peter G. Welling, Francis L.S. Tse, and Shrikant V. Dighe |
|
| 260 |
_aNew York : _bDekker, _cc1991 |
||
| 300 |
_aix, 467 pages : _billustrations ; _c23 cm. |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | _aPart one: Bioequivalence and Its Determination -- Part two: Species differences, pharmacodynamic models -- Part three: Perspectives of regulatory agencies, worldwide, on bioequivalence testing | ||
| 520 | _aIs essential reading for pharmacists adn pharmacologists, drug regulatroy personnel, and upper-level undergraduate and graduate students in these disciplines. | ||
| 650 | _aDRUGS -- THERAPEUTIC EQUIVALENCY | ||
| 700 |
_aWelling, Peter G. ;Tse, Francis L.S. ;Dighe, Shrikant V. _eeditor;editor;editor |
||
| 942 |
_2lcc _cBK |
||
| 999 |
_c6151 _d6151 |
||